High-sensitivity troponin I (hs-TnI) and troponin T (hs-TnT) are moderately correlated and independently related to outcome in atrial fibrillation (AF). Rate controlling therapy has been shown to reduce hs-TnT, however the potential impact on hs-TnI levels, and whether this differs from the effects on hs-TnT, has not been investigated previously.
Sixty patients with stable, permanent AF without heart failure or known ischemic heart disease were included in a randomised crossover study (mean age 71 ± 9 years, 18 women). Diltiazem 360 mg, verapamil 240 mg, metoprolol 100 mg, and carvedilol 25 mg were administered once daily for three weeks, in a randomised sequence. At baseline and on the last day of each treatment period, hs-TnI was measured at rest and after a maximal exercise test and compared to hs-TnT.
Hs-TnI and hs-TnT correlated moderately at baseline (rs = 0.582, p
Notes
Cites: Am Heart J. 2002 Aug;144(2):351-812177656
Cites: Neurology. 1978 Oct;28(10):973-7570666
Cites: Circulation. 1996 Oct 1;94(7):1585-918840848
Cites: J Am Coll Cardiol. 1997 Jul;30(1):260-3119207652